vs
Side-by-side financial comparison of Postal Realty Trust, Inc. (PSTL) and SCYNEXIS INC (SCYX). Click either name above to swap in a different company.
Postal Realty Trust, Inc. is the larger business by last-quarter revenue ($26.0M vs $18.6M, roughly 1.4× SCYNEXIS INC). SCYNEXIS INC runs the higher net margin — 65.7% vs 17.9%, a 47.9% gap on every dollar of revenue. On growth, SCYNEXIS INC posted the faster year-over-year revenue change (1808.5% vs 21.7%). Over the past eight quarters, SCYNEXIS INC's revenue compounded faster (268.5% CAGR vs 22.6%).
Postal Realty Trust, Inc. is a specialized real estate investment trust that acquires, owns, and manages properties primarily leased to the United States Postal Service. Its portfolio includes last-mile postal facilities, sorting centers, and retail post office locations across the U.S., supporting critical mail and package delivery infrastructure.
SCYNEXIS Inc. is a biotechnology company focused on developing innovative antifungal therapies to address unmet medical needs for difficult-to-treat fungal infections. It targets hospital and specialty care markets, with key product candidates serving immunocompromised patients and other high-risk groups.
PSTL vs SCYX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $26.0M | $18.6M |
| Net Profit | $4.6M | $12.3M |
| Gross Margin | — | — |
| Operating Margin | 39.2% | 56.3% |
| Net Margin | 17.9% | 65.7% |
| Revenue YoY | 21.7% | 1808.5% |
| Net Profit YoY | 3.1% | 376.5% |
| EPS (diluted) | $0.16 | $0.25 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $26.0M | $18.6M | ||
| Q3 25 | $24.3M | $334.0K | ||
| Q2 25 | $23.4M | $1.4M | ||
| Q1 25 | $22.1M | $257.0K | ||
| Q4 24 | $21.4M | $977.0K | ||
| Q3 24 | $19.7M | $660.0K | ||
| Q2 24 | $18.1M | $736.0K | ||
| Q1 24 | $17.3M | $1.4M |
| Q4 25 | $4.6M | $12.3M | ||
| Q3 25 | $3.8M | $-8.6M | ||
| Q2 25 | $3.6M | $-6.9M | ||
| Q1 25 | $2.1M | $-5.4M | ||
| Q4 24 | $4.5M | — | ||
| Q3 24 | $1.1M | $-2.8M | ||
| Q2 24 | $817.0K | $-14.5M | ||
| Q1 24 | $206.0K | $411.0K |
| Q4 25 | 39.2% | 56.3% | ||
| Q3 25 | 37.6% | -2516.5% | ||
| Q2 25 | 37.3% | -701.0% | ||
| Q1 25 | 28.4% | -3350.2% | ||
| Q4 24 | 43.2% | — | ||
| Q3 24 | 24.3% | -1563.6% | ||
| Q2 24 | 22.8% | -1255.0% | ||
| Q1 24 | 17.6% | -692.5% |
| Q4 25 | 17.9% | 65.7% | ||
| Q3 25 | 15.7% | -2572.2% | ||
| Q2 25 | 15.5% | -504.8% | ||
| Q1 25 | 9.4% | -2097.7% | ||
| Q4 24 | 21.1% | — | ||
| Q3 24 | 5.4% | -425.5% | ||
| Q2 24 | 4.5% | -1964.4% | ||
| Q1 24 | 1.2% | 29.9% |
| Q4 25 | $0.16 | $0.25 | ||
| Q3 25 | $0.13 | $-0.17 | ||
| Q2 25 | $0.12 | $-0.14 | ||
| Q1 25 | $0.06 | $-0.11 | ||
| Q4 24 | $0.17 | — | ||
| Q3 24 | $0.03 | $-0.06 | ||
| Q2 24 | $0.02 | $-0.30 | ||
| Q1 24 | $-0.01 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.5M | $40.0M |
| Total DebtLower is stronger | $361.1M | — |
| Stockholders' EquityBook value | $285.2M | $49.4M |
| Total Assets | $759.1M | $59.0M |
| Debt / EquityLower = less leverage | 1.27× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.5M | $40.0M | ||
| Q3 25 | $1.9M | $37.9M | ||
| Q2 25 | $1.1M | $44.8M | ||
| Q1 25 | $639.0K | $40.6M | ||
| Q4 24 | $1.8M | $59.3M | ||
| Q3 24 | $970.0K | $68.8M | ||
| Q2 24 | $1.7M | $73.0M | ||
| Q1 24 | $1.9M | $80.2M |
| Q4 25 | $361.1M | — | ||
| Q3 25 | $347.0M | — | ||
| Q2 25 | $328.8M | — | ||
| Q1 25 | $306.7M | — | ||
| Q4 24 | $296.7M | — | ||
| Q3 24 | $277.0M | — | ||
| Q2 24 | $273.7M | — | ||
| Q1 24 | $247.6M | — |
| Q4 25 | $285.2M | $49.4M | ||
| Q3 25 | $273.9M | $36.4M | ||
| Q2 25 | $250.8M | $44.5M | ||
| Q1 25 | $245.5M | $50.5M | ||
| Q4 24 | $251.3M | $55.1M | ||
| Q3 24 | $245.6M | $58.5M | ||
| Q2 24 | $245.5M | $60.4M | ||
| Q1 24 | $248.1M | $74.1M |
| Q4 25 | $759.1M | $59.0M | ||
| Q3 25 | $735.2M | $51.1M | ||
| Q2 25 | $689.8M | $60.7M | ||
| Q1 25 | $654.0M | $67.9M | ||
| Q4 24 | $646.8M | $90.6M | ||
| Q3 24 | $615.1M | $99.0M | ||
| Q2 24 | $608.2M | $107.8M | ||
| Q1 24 | $584.1M | $118.3M |
| Q4 25 | 1.27× | — | ||
| Q3 25 | 1.27× | — | ||
| Q2 25 | 1.31× | — | ||
| Q1 25 | 1.25× | — | ||
| Q4 24 | 1.18× | — | ||
| Q3 24 | 1.13× | — | ||
| Q2 24 | 1.11× | — | ||
| Q1 24 | 1.00× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $44.5M | $18.4M |
| Free Cash FlowOCF − Capex | $37.6M | — |
| FCF MarginFCF / Revenue | 144.5% | — |
| Capex IntensityCapex / Revenue | 26.7% | — |
| Cash ConversionOCF / Net Profit | 9.59× | 1.50× |
| TTM Free Cash FlowTrailing 4 quarters | $65.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $44.5M | $18.4M | ||
| Q3 25 | $10.9M | $-8.7M | ||
| Q2 25 | $11.4M | $-7.5M | ||
| Q1 25 | $10.8M | $-7.5M | ||
| Q4 24 | $33.5M | $-24.0M | ||
| Q3 24 | $8.0M | $765.0K | ||
| Q2 24 | $9.9M | $-10.9M | ||
| Q1 24 | $6.4M | $-4.0M |
| Q4 25 | $37.6M | — | ||
| Q3 25 | $8.8M | — | ||
| Q2 25 | $9.1M | — | ||
| Q1 25 | $10.2M | — | ||
| Q4 24 | $30.7M | — | ||
| Q3 24 | $7.4M | — | ||
| Q2 24 | $8.9M | — | ||
| Q1 24 | $5.8M | — |
| Q4 25 | 144.5% | — | ||
| Q3 25 | 36.1% | — | ||
| Q2 25 | 38.8% | — | ||
| Q1 25 | 45.9% | — | ||
| Q4 24 | 143.8% | — | ||
| Q3 24 | 37.6% | — | ||
| Q2 24 | 49.4% | — | ||
| Q1 24 | 33.6% | — |
| Q4 25 | 26.7% | — | ||
| Q3 25 | 8.9% | — | ||
| Q2 25 | 10.1% | — | ||
| Q1 25 | 3.0% | — | ||
| Q4 24 | 13.0% | — | ||
| Q3 24 | 3.2% | — | ||
| Q2 24 | 5.4% | — | ||
| Q1 24 | 3.5% | — |
| Q4 25 | 9.59× | 1.50× | ||
| Q3 25 | 2.87× | — | ||
| Q2 25 | 3.16× | — | ||
| Q1 25 | 5.20× | — | ||
| Q4 24 | 7.44× | — | ||
| Q3 24 | 7.48× | — | ||
| Q2 24 | 12.10× | — | ||
| Q1 24 | 31.07× | -9.75× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PSTL
Segment breakdown not available.
SCYX
| Glaxosmithkline Intellectual Property | $17.2M | 92% |
| Products | $1.4M | 8% |
